Overall Survival Data Collection Can Help Mitigate Bias In Open-Label Studies, US FDA Says

 
• By Sue Sutter
  
Crystal ball
Oncology sponsors need to plan ahead for ways to mitigate bias resulting from a potential loss of equipoise. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D